PRAXPraxis Precision Medicines, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+13% of shares).
Rangebound, no clear trend. Oversold (RSI 28). Price is −17% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PRAX is trading
Praxis Precision Medicines, Inc. is +515% over the past year while the S&P 500 is +18%: 497 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −17%
vs 200-day average · a clear downtrend
- RSI (14)
- 28
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 33%
Below its 52-week high
Details›
- Last close2026-10-09
- $259.82
- 1 monthS&P 500 +2.7%
- −23%
- 1 yearS&P 500 +18%
- +515%
- 5 yearsS&P 500 +88%
- −15%
- vs 50-day average$328.38
- −21%
- 52-week high
- $386.42
- 52-week low
- $48.33
- Annualised volatility
- 151%
| Year | Return |
|---|---|
| 2026 (year to date) | −12% |
| 2025 | +283% |
| 2024 | +245% |
| 2023 | −38% |
| 2022 | −88% |
| 2021 | −64% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +30% |
| Feb | 6 | 2 of 6 | −17% |
| Mar | 6 | 1 of 6 | −16% |
| Apr | 6 | 1 of 6 | −1.7% |
| May | 6 | 3 of 6 | −8.7% |
| Jun | 6 | 2 of 6 | −8.9% |
| Jul | 6 | 3 of 6 | +12% |
| Aug | 6 | 3 of 6 | +9.8% |
| Sep | 6 | 3 of 6 | −1.7% |
| Oct | 6 | 3 of 6 | +41% |
| Nov | 6 | 4 of 6 | +7.3% |
| Dec | 6 | 5 of 6 | +21% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.